Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
fda
life sciences
national
3
×
national blog main
national top stories
biotech
merck
new york blog main
new york top stories
roche
san francisco top stories
abbvie
allergan
amgen
billy dunn
biogen
biohaven
blueprint medicines
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cgpr
companion diagnostic
detroit blog main
detroit top stories
dna sequencing
drug prices
drug pricing
drugs
eli lilly
entrectinib
europe blog main
europe top stories
evrysdi
express scripts
foundation medicine
gene therapy
What
approved
3
×
fda
new
3
×
drug
medicine
adults
allergan
atrophy
cancer
class
daily
deeper
dna
evrysdi
fingerprint
friday
genetic
going
green
home
intended
lights
liquid
matter
medicines
migraine
monday
muscular
nd
nod
oks
oral
patients
pill
risdiplam
roche
second
spinal
targets
therapy
Language
unset
Current search:
approved
×
national
×
new
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues